Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Yano, Tomonori ^a   Muto, Manabu ^b   Yoshimura, Kenichi ^c   Niimi, Miyuki ^c   Ezoe, Yasumasa ^b   Yoda, Yusuke ^a   Yamamoto, Yoshinobu ^d   Nishisaki, Hogara ^d   Higashino, Koji ^e   Iishi, Hiroyasu ^e  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d HYOGO CANCER CENTER   (Japan)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Esophageal cancer; Phase I study; Photodynamic therapy; Salvage treatment; Talaporfin sodium

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN; TALAPORFIN;

ADULT; AGED; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; DIODE LASER; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TREATMENT FAILURE; DYSPHAGIA; ESOPHAGUS CANCER; ESOPHAGUS PAIN; FEMALE; FEVER; HUMAN; MALE; MULTICENTER STUDY; NAUSEA; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; TREATMENT FAILURE;

EID: 84864767819     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-113     Document Type: Article

References (19)

1. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326:1593-8. 10.1056/NEJM199206113262403, 1584260.
2. Swisher SG, Wynn P, Putnum JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002, 123:173-83.
3. Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Mori M, Doki Y. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 2009, 100:442-6. 10.1002/jso.21353, 19653262.
4. Tachimori Y, Kanamori N, Uemura N, Hosokawa N, Igaki H, Kato H. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2009, 137:49-54. 10.1016/j.jtcvs.2008.05.016, 19154902.
5. Chao YK, Chan SC, Chang HK, Liu YH, Wu YC, Hsieh MJ, Tseng CK, Liu HP. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Eur J Surg Oncol 2009, 35(3):289-94. 10.1016/j.ejso.2008.02.014, 18396384.
6. Onozawa M, Nihei K, Ishikura S, Minashi K, Yano T, Muto M, Ohtsu A, Ogino T. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of thoracic esophagus. Radiother Oncol 2009, 92:266-9. 10.1016/j.radonc.2008.09.025, 18952308.
7. Yano T, Muto M, Minashi K, Ohtsu A, Yoshida S. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2005, 62:31-6. 10.1016/S0016-5107(05)00545-6, 15990816.
8. Yano T, Muto M, Minashi K, Onozawa M, Nihei K, Ishikura S, Kaneko K, Ohtsu A. Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 2011, 43(8):657-63. 10.1055/s-0030-1256373, 21623555.
9. Yano T, Muto M, Minashi K, Iwasaki J, Kojima T, Fuse N, Doi T, Kaneko K, Ohtsu A. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: a phase II study. Int J Cancer 2011, [Epub ahead of print].
10. Kato H, Furukawa K, Sato M, Okunak T, Kusunoki Y, Kawahara M, Fukuoka M, Miyazawa T, Yana T, Matsui K, Shiraishi T. Phase II clinical study of photodynamic therapy using mono-L-asparthyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 2003, 42:103-111. 10.1016/S0169-5002(03)00242-3, 14512194.
11. Horimatsu T, Muto M, Yoda Y, Yano T, Ezoe Y, Miyamoto S, Chiba T. Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium (Laserphyrin): a preclinical study. PLoS ONE 2012, 7(6):e38308. 10.1371/journal.pone.0038308, 3374776, 22719875.
12. TNM Classification of Malignant Tumours 2002, Wiley-Liss, New York, Sobin LH, Wittekind C, 6.
13. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus 2007, The Japan Esophageal Society, 10.
14. Atkinson M, Ferguson R, Ogylvie AC. Management of malignant dysphagia by intubation at endoscopy. J Roy Soc Med. 1979, 27:894-7.
15. Common Terminology Criteria for Adverse Events (CTCAE) v 4.0 published May 28,2009 URL http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40.
16. Conroy T, Etienne PL, Adenis A, Wagener DJ, Paillot B, François E, et al. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. J Clin Oncol 1996, 14:164-70.
17. Lordick F, von Schilling C, Bernhard H, Hennig M, Bredenkamp R, Peschel C. Phase II study of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer. Br J Cancer 2003, 89:630-3. 10.1038/sj.bjc.6601168, 2376928, 12915869.
18. Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, Fujita H, Takiyama W, Ohtsu T. A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 2004, 15:955-9. 10.1093/annonc/mdh231, 15151954.
19. Park BB, Im YH, Hwang IG, Lee SC, Ahn JS, Ahn MJ, Lim HY, Kang WK, Park K, et al. Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma. Invest News Drugs 2008, 26:387-92.